Bupropion for the Treatment of Methamphetamine Dependence - 1

• Status: Completed
• Trial end date: 2005-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy and safety of bupropion in reducing methamphetamine use in subjects with methamphetamine dependence

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Treatments: Bupropion; Methamphetamine

Criteria

Inclusion Criteria:

• Subject must have methamphetamine dependence as determined by the DSM-IV diagnosis

• Subject must be willing to comply with study procedures.

• Ability to verbalize understanding of consent form, provide written consent, and verbalize willingness to complete study procedures

• Be able to comply with protocol requirements

Exclusion Criteria:

• Please contact site for more information.